<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Bayas A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Symptomatic and asymptomatic delayed non-ischemic cerebral enhancing (NICE) lesions in magnetic resonance imaging (MRI) have been reported as a rare complication after endovascular therapy (EVT) in recent years with incidence rates between 0.05% and 0.9% in most studies. Information on long-term clinical course and immunotherapies is scarce or has not been reported in detail in the literature. Objective: Aims of our study were to assess the incidence of NICE lesions in patients after cerebral EVT over a period of more than 12 years, describe clinical and EVT characteristics, and immunotherapies applied.&lt;h4>Methods&lt;/h4>A retrospective chart review of all patients treated by endovascular therapy for symptomatic or asymptomatic aneurysms at the University Hospital of Augsbu</pubmed_abstract><journal>Therapeutic advances in neurological disorders</journal><pagination>17562864211072372</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8808010</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Incidence, clinical spectrum, and immunotherapy of non-ischemic cerebral enhancing lesions after endovascular therapy.</pubmed_title><pmcid>PMC8808010</pmcid><pubmed_authors>Welzel J</pubmed_authors><pubmed_authors>Muller M</pubmed_authors><pubmed_authors>Bayas A</pubmed_authors><pubmed_authors>Maurer C</pubmed_authors><pubmed_authors>Christ M</pubmed_authors><pubmed_authors>Berlis A</pubmed_authors><pubmed_authors>Ann Gerdes L</pubmed_authors><pubmed_authors>Ertl M</pubmed_authors><pubmed_authors>Naumann M</pubmed_authors><pubmed_authors>Seelos K</pubmed_authors><pubmed_authors>Joachimski F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Incidence, clinical spectrum, and immunotherapy of non-ischemic cerebral enhancing lesions after endovascular therapy.</name><description>&lt;h4>Background&lt;/h4>Symptomatic and asymptomatic delayed non-ischemic cerebral enhancing (NICE) lesions in magnetic resonance imaging (MRI) have been reported as a rare complication after endovascular therapy (EVT) in recent years with incidence rates between 0.05% and 0.9% in most studies. Information on long-term clinical course and immunotherapies is scarce or has not been reported in detail in the literature. Objective: Aims of our study were to assess the incidence of NICE lesions in patients after cerebral EVT over a period of more than 12 years, describe clinical and EVT characteristics, and immunotherapies applied.&lt;h4>Methods&lt;/h4>A retrospective chart review of all patients treated by endovascular therapy for symptomatic or asymptomatic aneurysms at the University Hospital of Augsbu</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-04T19:54:40.619Z</modification><creation>2025-04-04T19:54:40.619Z</creation></dates><accession>S-EPMC8808010</accession><cross_references><pubmed>35126670</pubmed><doi>10.1177/17562864211072372</doi></cross_references></HashMap>